The stock of Guardion Health Sciences, Inc. (NASDAQ:GHSI) reached all time low today, Aug, 8 and still has $0.58 target or 7.00 % below today’s $0.62 share price. This indicates more downside for the $14.10 million company. This technical setup was reported by Barchart.com. If the $0.58 PT is reached, the company will be worth $986,790 less.
Trading stocks at an all time low is not easy. Stock at an all time low usually experience even more downside due to very negative fundament. Even thought the pullback rate is high, shorting is not an easy job because the risk of being wrong is big and the risk-reward ratio is always worse than if trading lon only.

The stock decreased 18.41% or $0.1399 during the last trading session, reaching $0.6201. About 196,857 shares traded. Guardion Health Sciences, Inc. (NASDAQ:GHSI) has 0.00% since August 8, 2018 and is . It has by 0.00% the S&P500.

More notable recent Guardion Health Sciences, Inc. (NASDAQ:GHSI) news were published by: Seekingalpha.com which released: “Guardion Health Sciences Begins U.S. IPO Effort – Seeking Alpha” on November 02, 2018, also Prnewswire.com with their article: “WallachBeth Capital Announces Completion of the $5 Million IPO for Guardion Health Services – PRNewswire” published on April 11, 2019, Benzinga.com published: “Mid-Day Market Update: Nu Skin Falls On Lowered Guidance; Guardion Health Sciences Shares Jump – Benzinga” on July 17, 2019. More interesting news about Guardion Health Sciences, Inc. (NASDAQ:GHSI) were released by: Nasdaq.com and their article: “Macular degeneration company Guardion Health Sciences files for a $10 million IPO – Nasdaq” published on October 31, 2018 as well as Benzinga.com‘s news article titled: “Wednesday’s Big Winner: Guardion Health Sciences – Benzinga” with publication date: July 17, 2019.

Guardion Health Sciences, Inc., a specialty health sciences company, develops, formulates, and distributes condition-specific medical foods in the United States and internationally. The company has market cap of $14.10 million. It operates in two divisions, Medical Foods and Vision Testing Diagnostics. It currently has negative earnings. The Medical Foods segment offers Lumega-Z, a medical food that replenishes and restores the macular protective pigment; MapcatSF, a medical device that measures the macular pigment optical density; and GlaucoCetin, a vision-specific medical food to support and protect the mitochondrial function of optic nerve cells, as well as improve blood flow in the ophthalmic artery in patients with glaucoma.

Receive News & Ratings Via Email – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with our FREE daily email newsletter.



Source link

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *